April 16 - 17, 2018 ~ Los Angeles
Special Discount for U.S. Commercial Service Clients, enter code: USCS-AP2018
Now in its 31st year, Asia/Pacific Business Outlook (APBO) is North America’s premier event for business leaders who want to expand their trade and investment in the Asia/Pacific region. The USC Marshall School of Business and the U.S. Department of Commerce have been working together on APBO since 1988 to help exporters take advantage of tremendous opportunities and overcome challenges in the constant changing economies of Asia. More than just a business conference, APBO is a comprehensive networking and learning experience designed to provide business leaders with the contacts and the latest, relevant and valuable information available–all focused, organized and distilled into two invaluable days.
The conference attracts a nationwide group of about 300 American executives who operate throughout the Asia/Pacific region. The conference provides a unique mixture of over 50 leading academic, business and government experts to advise a diverse audience of American firms on how to become more competitive in the dynamic Asia/Pacific marketplace, including private one-on-one appointments with senior commercial officers from American embassies and consulates in 18 economies.
Access 18 Markets in Two Days
Australia, Cambodia, Canada, China, Hong Kong, India, Indonesia, Japan, Korea, Malaysia, Mexico, Myanmar, New Zealand, Philippines, Singapore, Taiwan, Thailand, Vietnam
Contacts for APBO: email@example.com or tel: 213.740.7130 www.apboconference.com
U.S. Commercial Service Contacts
Jason Sproule -
U.S. Commercial Service, Los Angeles. Tel: 949-283-0690, Jason.Sproule@trade.gov
Erica Ramirez -
U.S. Commercial Service, Irvine, Tel: 949-660-7105, Erica.Ramirez@trade.gov
The Asia Pacific region has many high potential growth markets for the Healthcare industry. According to Frost and Sullivan, Asia Pacific’s healthcare market is estimated to contribute close to 33% of the global healthcare market and estimated to be valued at $521 billion, with trends in the medical device industry in Asia mainly centered on imaging, cardiovascular, and healthcare IT.
Including the aforementioned, the Asia Pacific Business Outlook Conference in 2018 will host 18 global markets from the Asia Pacific region and allows for direct access to industry and market experts. Learn More.
- Japan ranked #1 among 80 countries according to ITA’s country case studies on healthcare IT metrics.
- A large Health IT market size (exceeding $1 billion).
- Japan’s total imports of U.S. pharmaceuticals totaled $5.7 billion in 2015, a 6% market share.
- Under the JFY2017 plan, the Pharmaceuticals and Medical Devices Agency aims to complete the review of 80% of new drugs (which are considered standard products) in 12 months (up from 70% in JFY 2016).
- Nikkei also reported that METI aims to foster the biotech-based economy as large as six times by the year 2030 through the development and commercialization of the innovative technologies, products and services including regenerative medicine, genome modification with the use of microorganism and plants
- According to the World Health Organization (WHO), Singapore’s healthcare system ranks sixth globally and offers the fourth best healthcare infrastructure in the world.
- Each year, Singapore draws over 350,000 patients with its high-quality healthcare.
- The Health Ministry’s 2017 budget is $7.4 billion and the government’s projected healthcare spending is expected to rise to $9.6 billion per year by 2020.
- More than 400,000 diabetics, costing Singapore over US$740 million yearly. This is expected to rise to US$1.8 billion if the trend is not arrested.
- The three key areas of focus are healthcare infrastructure, healthcare delivery, and managing the associated costs and issues related to an aging population.
- In 2016, the total trade for Malaysia’s medical device industry was approximately US$2 billion and it imported $585 million of medical devices.
- U.S. products represented 18.4 percent of the import market and the U.S. was the top exporting country of medical devices to Malaysia in the same year.
- Public budget allocations for developmental projects - $1 billion operation costs for rural, urban and mobile clinics | $900 million for the supply of drugs, vaccines, reagents and consumables to all public healthcare systems | $122 million upgrade to cardiology treatment equipment and purchase of 100 ambulances | $18 million prevention and control of contagious diseases (Dengue, Zika) | $16 million underprivileged patient’s medical assistance program.